Tegafur–Uracil/Leucovorin Plus Oxaliplatin (TEGAFOX) as Consolidation Regimen after Short-Course Radiotherapy Is Effective for Locally Advanced Rectal Cancer

This study aimed to explore the safety and efficacy of neoadjuvant SCRT and tegafur–uracil/leucovorin plus oxaliplatin (TEGAFOX) for LARC in comparison to those of the modified 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX-6) regimen. We retrospectively evaluated 15 and 22 patients with LARC...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Chun-Kai, Kuo, Ya-Ting, Chern, Yih-Jong, Hsu, Yu-Jen, Lin, Yueh-Chen, Yu, Yen-Lin, Hsieh, Pao-Shiu, Chiang, Jy-Ming, Yeh, Chien-Yuh, You, Jeng-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146085/
https://www.ncbi.nlm.nih.gov/pubmed/35629045
http://dx.doi.org/10.3390/jcm11102920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146085/
https://www.ncbi.nlm.nih.gov/pubmed/35629045
http://dx.doi.org/10.3390/jcm11102920

Ejemplares similares